SCD and Parkinson disease: For instance, the brain-penetrant SCD inhibitor 5b was demonstrated to be protective in the 3 K mouse model, in which mice have an amplified familial PD α-syn mutation (E35K + E46K + E61K [“3K”]), making α-syn more prone to aggregation [98, 99].